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Abstract 
Ulcerative colitis (UC) is one of the major forms of inflammatory bowel disease with unknown 
cause. A molecular marker, WAFL, has recently been found to be up-regulated in the inflamed 
colonic mucosa of UC patients. Towards understanding biological function of WAFL, we 
analyzed proteins interacting with WAFL in HEK-293 cells by immunoprecipitation and mass 
spectrometry. Among four proteins found to specifically interact with WAFL, both KIAA0196 
and KIAA1033 bind to α-appendage of the adaptor protein complex 2 (AP2), which acts as an 
interaction hub for accessory proteins in endocytosis mediated by clathrin-coated vesicle 
(CCV). The specific interaction between WAFL and KIAA0196 was also confirmed in human 
colorectal carcinoma HCT-116 cells by co-immunoprecipitation with specific antibodies. 
Meta-analyses of the databases of expressed genes suggest that the three genes are 
co-expressed in many tissues and cell types, and that their molecular function may be classified 
in the category of ‘membrane traffic protein’. Therefore, these results suggest that WAFL may 
play an important role in endocytosis and subsequent membrane trafficking by interacting with 
AP2 through KIAA0196 and KIAA1033.  
Key words: Inflammatory bowel disease, Proteomics, WAFL/FKBP15/FKBP133/KIAA0674, 
KIAA1033, KIAA0196/strumpellin, Wiskott-Aldrich syndrome protein 
1. Introduction 
Inflammatory bowel disease (IBD) is a complex 
polygenic chronic inflammatory disease of the ga-
strointestinal tract with unknown cause, and is in 
need of additional biomarkers in order to subgroup 
different forms of IBD. In its current setting, IBD is 
classified into two major forms, Crohn’s disease (CD) 
and UC [1-4]. Although CD and UC are two major 
clinically different diseases, there is correlation be-
tween their genetic backgrounds, and diagnosis is 
made difficult when disease manifestations overlap 
[5-7]. Nine IBD susceptibility loci have been identified 
and confirmed by linkage studies [8]. The CARD15 
gene coding for NOD2, an intracellular peptidoglycan 
receptor, has been identified to be linked to CD [9,10]. 
A recent genome-wide association study has identi-
fied UC-risk loci encompassing genes, PLA2G2E, 
IFNG, IL26 and IL22, as well as associations between 
UC and the MHC region, and between UC and IL23R 
[11]. 
Through a differential gene expression screen 
using subtractive suppression hybridization, it has 
recently been found that the WAFL (WASP and 
FKBP-like protein; also known as 
FKBP15/FKBP133/KIAA0674 [12,13]) gene, which en-
codes a novel protein with homologies to WASP and 
FKBP (FK506-binding protein), was up-regulated in Int. J. Biol. Sci. 2010, 6 
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the inflamed colonic mucosa of UC patients, but not of 
CD [14]. The WAFL protein has recently been found 
to associate with early endosomes, and to move along 
microtubule tracks. In addition, WAFL also interacts 
with WASP-interacting protein (WIP) and actin [15]. 
The mouse homolog of WAFL was reported to par-
tially co-localize with F-actin in the growth cones of 
dorsal root ganglion neurons [13]. These results sug-
gest that WAFL may be involved in the transport of 
early endosomes by interacting with endosomes, mi-
crotubules and actin filaments. However, how WAFL 
interacts with endosomes and microtubules is un-
known.  
To explore biological and pathological roles of 
WAFL, we have investigated the interactome of 
WAFL in HEK-293 cells by co-immunoprecipitation, 
PAGE and LC-MS/MS, and have found that WAFL 
specifically interacts with accessory proteins involved 
in endocysis. This result was further supported by a 
meta-analysis of gene expression profiles of the inte-
racting partners in the Oncomine database [16,17] as 
well as by gene ontology analysis of the PANTHER 
database [18], and was confirmed by 
co-immunoprecipitation of human colorectal carci-
noma HCT-116 cells with specific antibodies.  
2. Materials and Methods 
Cell lines and transfection 
 Chemicals and reagents used in this study were 
purchased from Sigma (St. Louis, MO) except for 
those otherwise specified. HEK-293 cells and HCT-116 
cells were cultured in minimum essential medium 
(MEM; Invitrogen, Carlsbad, CA) with 10% fetal bo-
vine serum (FBS; Invitrogen) and 1.0% (v/v) penicil-
lin/streptomycin (Invitrogen) at 37ºC in a 5% (v/v) 
CO2 humidified atmosphere. The full-length WAFL 
cDNA (3757 bp) was cloned into pCMV·SPORT6 
plasmid (Invitrogen) between Sal I and Apa I sites. The 
insert also encoded the WAFL protein fused with a 
FLAG tag at its C-terminus.  
Co-immunoprecipitation and Western blotting 
 HEK-293 cells expressing the full-length WAFL 
protein with a FLAG tag were lysed in lysis buffer (20 
mM Tris-HCl, pH 7.5, 150 mM NaCl, 1.0 mM EDTA, 
1.0 mM EGTA, 1% (v/v) Triton X-100, 2.5 mM sodium 
pyrophosphate, 1.0 mM beta-glycerophosphate, 1.0 
mM Na3VO4, 1.0 µg/ml leupeptin, and protease inhi-
bitor cocktail (x 1) (Roche Singapore)) for 1.0 h at 4°C. 
After centrifuging for 10 min at 13,000 rpm, the su-
pernatant was immunoprecipitated with anti-FLAG 
M2 affinity gel and eluted according to the manufac-
turer’s instructions (Sigma).  
The eluted protein samples were separated by 
10% SDS-PAGE, and were stained with Coomassie 
Brilliant Blue G-250 (CBB; Thermo Fisher, Pittsburgh, 
PA) or transferred to a nitrocellulose filter. The 
membrane was incubated with primary antibody 
(anti-FLAG M2 antibody; F3165) at a concentration of 
2.5  μg/ml and then secondary antibody (goat an-
ti-mouse immunoglobulin G antibody; A9044) at a 
concentration of 0.5 μg/ml. The blot was stained by 
using ECL reagents (GE Healthcare, Little Chalfont, 
UK), and was exposed to X-ray film. 
Human HCT-116 cell line, purchased from the 
American Type Culture Collection (ATCC; Manassas, 
VA), was cultivated in MEM as described above, and 
was used for co-immunoprecipitation and Western 
blotting analyses using antibodies, HPA007979 (Sig-
ma) and sc-87442 (Santa Cruz Biotechnology, Santa 
Cruz, CA), specific for WAFL and KIAA0196, respec-
tively. In brief, HCT-116 cell lysates (~107 cells in 1.0 
ml each) prepared as described above were precleared 
with 30 μl protein A-Sepharose 4B (101142; Invitro-
gen) for 3 h at 4oC, and then after removing the beads 
by centrifugation, the supernatants were incubated 
with antibody, 3 μg, at 4oC overnight. Resulting anti-
body-protein complexes were collected by incubating 
the solution with 30 μl of protein A-Sepharose beads 
for 2 h at 4oC, and then after centrifugation, the beads 
were washed three times with TBS (50 mM Tris-HCl, 
pH 7.4, and 150 mM NaCl) buffer, 1.5 ml, for 10 min at 
4oC. Proteins were eluted by 70 μl of 0.1 M glycine 
buffer, pH 2.5, for 20 min at room temperature, and 
were neutralized with 10 μl of 1.0 M Tris-HCl, pH 8.5. 
Rabbit serum IgG (sc-2027; Santa Cruz) was used as a 
negative control. Western blotting was performed as 
described above.  
LC-MS/MS 
 Cell lysates and protein samples were separated 
by 10% SDS-PAGE. After staining with CBB G-250 or 
with a silver stain plus kit (BIO-RAD, Hercules, CA), 
protein bands were excised out and were then trans-
ferred to polypropylene tubes. The excised gels were 
washed three times with a 1:1 mixture of acetonitrile 
and 50 mM ammonium bicarbonate for 15 min, dried 
and then reduced with 10 mM dithiothreitol for 1.0 h 
at 55ºC. After 55 mM iodoacetamide treatment fol-
lowed by incubation in dark for 45 min at room tem-
perature, the gel pieces were washed with 100 mM 
ammonium bicarbonate for 5 min with vortexing, and 
then with a 1:1 mixture of acetonitrile and 50 mM 
ammonium bicarbonate for 5 min. The resulting gel 
pieces were dehydrated with acetonitrile, and were 
dried up.  
In-gel digestion of proteins was performed by 
adding 50 mM ammonium bicarbonate containing 2.6 Int. J. Biol. Sci. 2010, 6 
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ng/µl modified trypsin (Promega, Madison, WI) and 
incubated in a water bath for 16 h at 37°C. Tryptic 
peptides  were extracted twice in extraction buffer 
(0.1% (v/v) trifluoroacetic acid, 50% acetonitrile, pH 
2.5) by sonicating for 20 min. The peptide solution 
was dried in a Speed-Vac (Thermo Savant, Marietta, 
OH) to reduce the volume and was adjusted to 100 µl 
with 100 mM ammonium bicarbonate before loading 
onto LC-MS/MS. 
The peptide samples were analyzed with a Fin-
nigan Surveyor HPLC system coupled online to a 
LTQ ion trap mass spectrometer (Thermo Electron, 
San Jose, CA) equipped with a nano-ESI source. The 
MS scan range was 200-2000 m/z and mass spectra 
were collected in data-dependent MS/MS mode in 
which five of the highest intensity peaks in each MS 
scan were chosen for collision-induced dissociation 
(CID), with an isolation width of 3 Da.   
LC-MS/MS data analysis 
 MS/MS data were analyzed by using Mascot 
(Matrix Science, London, UK). Database search was 
performed with a carbaminomethylation (Cys) set as 
fixed modification, oxidized methionine (+16 Da) as 
variable modifications. Missed cleavages of trypsin 
were set as one. Peptide charges were confined to 2+ 
and 3+, and mass tolerance was set to 2.0 Da for par-
ent ions and 0.8 Da for product ions, respectively. 
Identifications were accepted with at least three con-
secutive y- and b- ions pair and a minimum ions score 
of 40. Details of ions score and nomenclature for ‘b’ 
and ‘y’ ions were previously described [19].  Three 
independent experiments were carried out. One rep-
resentative result was selected and the interacting 
proteins detected in at least two experiments are 
shown.   
Meta-analysis of WAFL- interacting partners 
 Meta-analysis of expression profiles of 
WAFL-interacting partner genes was carried out by 
retrieving studies from the Oncomine database 
[16,17]. Similar meta-analysis has been successfully 
applied for the identification of signaling pathway 
components mediated by the estrogen receptor after 
retrieving top 21 studies from the database [20,21]. 
Co-occurrence of two factors (co-expression of two 
genes) for each study was compared among a set of 
co-expressed genes after removing duplicates and 
ESTs. The correlation network of co-expressed genes 
was constructed by assuming that two genes 
co-expressed at higher frequencies would be more 
functionally correlated and would more closely inte-
ract with each other. 
Gene ontology analysis of WAFL and its inte-
racting partners was carried out using the PANTHER 
database as previously described [18,22]. Top 1,000 
genes highly co-expressed were selected as input data 
from the database, and were compared with the NCBI 
reference gene set. Statistically significantly (p < 0.01) 
enriched PANTHER gene ontology categories were 
identified.  
3. Results and Discussion 
After transfection of an expression plasmid en-
coding the full-length WAFL with a FLAG tag into 
HEK-293 cells, the WAFL protein was partially puri-
fied by immunoprecipitation with anti-FLAG anti-
body, and analyzed by SDS-PAGE. When the gel was 
stained with CBB, a single protein band was observed 
(data not shown). When analyzed by Western blotting 
with anti-FLAG antibody, furthermore, a single band 
was also observed in the immunoprecipitate or total 
lysate of HEK-293 cells harboring the expression 
plasmid encoding the WAFL-FLAG fusion protein 
(Fig. 1A, lanes #1 and #3); the faint band above the 
main band in lane #1 was also observed as an un-
known protein when exposed for a longer period of 
time. These results indicated that the main band cor-
responds to the WAFL protein with a FLAG tag. 
Therefore, we analyzed the single band in the 
CBB-stained gel by LC-MS/MS after being excised out 
from the gel. The results confirmed that the band was 
indeed the WAFL protein (data not shown). When the 
gel was stained with more sensitive silver staining, 
many other bands were also detected (Fig. 1B, lane 
#1). Among these bands, six bands were specifically 
detected only in the immunoprecipitate from 
HEK-293 cells expressing the WAFL-FLAG fusion 
protein, but not in cells untransfected. These six bands 
were excised out and analyzed by LC-MS/MS. The 
results are summarized in Table 1.  
The band #1 in Fig. 1B showed the highest in-
tensity, and was identified with the highest Mascot 
score, 1495, as the WAFL protein itself (Fig. 2A). The 
WAFL protein was found in all the bands #1 through 
#6, and smaller bands than the band #1 might be 
cleaved products since their sequence coverage was 
less than that of the band #1, which covered 35% of 
the full length by the largest number, 110, of unique 
peptides. Band #3 contained a hypothetical protein, 
KIAA1033 (Fig. 2C), and tau tubulin kinase 2 (TTBK2) 
in addition to WAFL. The KIAA0196 protein (Fig. 2B) 
was found as a major component of band #4 in addi-
tion to WAFL and TTBK2. Polyubiquitin encoded by 
UBC w a s  a l s o  i d e n t i f i e d  i n  b a n d  # 6  i n  a d d i t i o n  t o  
WAFL.  
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Fig. 1. (A) Western blot analysis of the WAFL protein fused with a FLAG tag. 
HEK-293 cells were transfected with an expression plasmid encoding the 
WAFL-FLAG fusion. The cells were lysed, and then immunoprecipitated with 
anti-FLAG antibody. Proteins before and after the immuntoprecipitation were 
resolved by SDS-PAGE. After the electrophoresis, proteins were transferred 
onto a membrane filter and detected with anti-FLAG antibody. Lane #1: im-
munoprecipitate from cells transfected; #2: immunoprecipitate from cells un-
transfected; #3: total proteins from cells transfected; #4: total proteins from cells 
untransfected. Positions of molecular standards are also shown on the right 
margin. (B) Proteins co-immunoprecipitated with the WAFL-FLAG fusion pro-
tein by using immobilized anti-FLAG antibody. After separating eluates from the 
resin by SDS-PAGE, proteins were silver-stained. Lane #1: immunopriciptate 
from cells transfected; #2: immunopriciptate from cells untransfected; #3: im-
munoprecipitate from lysis buffer (negative control); #4: eluate from anti-FLAG 
antibody resin used for the immunoprecipitation (negative control). Protein 
bands on the lane #1 that were not observed in lane #2 are indicated by arrows 
with numbers on the left margin. Positions of molecular standards are also shown 
on the right margin. (C) Co-immunoprecipitation (IP) of the KIAA0196 protein 
with antibody specific for WAFL. Human HCT-116 cell lysate was reacted with 
antibody specific for WAFL, and the resulting complex was precipitated with 
protein A-Sepharose. The protein complex was eluted from the Sepharose 
beads, was resolved by SDS-PAGE, and was analyzed by Western blotting (WB) 
with antibody specific for KIAA0196. (D) Co-immunoprecipitation of WAFL with 
antibody specific for the KIAA0196 protein. 
 
 
 
 
 
 
 
 
Table 1 Proteins co-immunoprecipitated with WAFL/KIAA0674. 
Band# Access#
a Identification Mr (Da) Score  Uniq. 
peptide# 
Seq. 
Cover. 
(%) 
1 T00363  WAFL  135609  1495  110  35 
2 T00363  WAFL  135609  1051  102  29 
3 T00363  WAFL  135609  933  81  22 
 Q2M389  KIAA1033  137357  488  46  22 
 Q8IWY7  TTBK2  183893  62  7  3 
4 Q53EL1  KIAA0196 135670  1407  98  36 
 T00363  WAFL  135609  175  16  14 
 Q8IWY7  TTBK2  183893  50  4  4 
5 T00363  WAFL  135609  383  40  17 
6 T00363  WAFL  135609  163  3 5 
 BAA23486  Polyubiquitin/UBC  68448  248  2  4 
 Q8IWY7  TTBK2  183893  51  3  4 
a UniProt accession# Int. J. Biol. Sci. 2010, 6 
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The results shown above indicated that 
KIAA1033, KIAA0196, polyubiquitin, and TTBK2 in-
teracted with WAFL in HEK-293 cells. Among these 
proteins, KIAA0196 (also known as strumpellin [23]) 
had the highest Mascot score, 1407, and 36% of its 
entire sequence was covered by the largest number, 
98, of unique peptides (Table 1). This specific interac-
tion between WAFL and KIAA0196 was also con-
firmed in human colorectal carcinoma HCT-116 cells 
under physiological conditions by 
co-immunoprecipitation with specific antibodies for 
WAFL and KIAA0196. When HCT-116 cell lysate was 
incubated with rabbit serum IgG or rabbit anti-WAFL 
antibody (αWAFL), KIAA0196 was specifically 
co-immunoprecipitated with WAFL, but not by using 
the reference serum IgG (Fig. 1C). Similarly, WAFL 
was specifically co-immunoprecipitated with 
KIAA0196 by using anti-KIAA0196 antibody 
(αKIAA0196; Fig. 1D). As observed in Fig. 1A, a minor 
band with a higher molecular mass than WAFL was 
again observed when the Western blot was exposed 
for a longer period of time (Fig. 1D). This may be an 
alternative form of the WAFL protein that was 
post-translationally modified since this faint band 
was detected with two distinct, anti-FLAG and 
anti-WAFL, antibodies. The KIAA0196 gene was 
mutated in patients with hereditary spastic 
paraplegia, a progressive upper-motor neurode-
generative disease [22]. KIAA1033 also had a high 
Mascot score, 488, and 22% of its entire sequence was 
covered by a large number, 46, of unique peptides 
(Table 1).    
To further understand the relationship between 
these interacting partners identified by mass spec-
trometry, we retrieved 20 studies from the Oncomine 
database [16,17] for each of the interacting partner 
genes, and analyzed the co-occurrence of the gene 
with other interacting partner genes. The two-factor 
analysis showed that WAFL co-occurred most fre-
quently with KIAA1033 (40%); KIAA0196 with 
KIAA1033 (35%) and UBC (35%); KIAA1033 with UBC 
(45%); UBC with KIAA1033 (35%); and TTBK2 with 
KIAA1033 (40%). Results of the three-factor 
co-occurrence analysis are also consistent with those 
of the two-factor analysis (data not shown). Fig. 3A 
summarizes these results by joining with solid lines 
two genes that showed the highest frequency of 
co-occurrence among all the combinations, and with 
dashed lines all the other combinations with less fre-
quent co-occurrences. The significantly frequent 
co-occurrences of WAFL/FKBP15, KIAA0196, 
KIAA1033, UBC and TTBK2 are consistent with the 
results of the study above using mass spectrometry. 
Among the co-occurrences, KIAA1033 had the highest 
frequencies of co-occurrences with all the other genes.  
We also performed the PANTHER analysis [18] 
of top 1,000 co-expressed genes with the five genes 
WAFL, KIAA0196, KIAA1033, UBC and TTBK2 in or-
der to explore their physiological functions by eluci-
dating functional categories in that the genes are 
commonly expressed. In addition to the categories 
‘kinase’ and ‘protein kinase’, the category ‘membrane 
traffic protein’ as ‘molecular function’ was commonly 
found for the three genes WAFL, KIAA0196 and 
KIAA1033 (Fig. 3B-D). These results suggest that 
WAFL may be involved in membrane trafficking by 
interacting with KIAA0196 and KIAA1033. Indeed, 
Schmid  et al [24] reported that KIAA0196 and 
KIAA1033 are interacting partners of α-appendage, 
but not β-appendage, of AP2. The AP2 α- and 
β-appendages act as interaction hubs for accessory 
proteins which are involved in CCV formation. Thus, 
these meta-analyses also suggest functional interac-
tions among WAFL, KIAA1033 and KIAA0196, con-
sistent with the results in the present study using 
co-immunoprecipitation followed by mass spectro-
metry. Therefore, WAFL may play a role in endocy-
tosis and subsequent membrane trafficking through 
interaction with KIAA0196, KIAA1033 and other 
proteins. The WAFL protein consists of at least four 
domains, WH1 (WASP homology 1; amino-acid re-
sidues 69-171), FKBP (aa 178-290), coiled coil (aa 
~500-~950) and C-terminal acidic end (aa 1185-1219) 
[14]. The WH1 domain and the acidic C-terminus are 
also found in the WASP family of actin polymeriza-
tion regulators, which activate an actin-related protein 
(Arp2/3) complex and consequently stimulate actin 
filament assembly [25]. It seems that WAFL interacts 
with endosomes via its central coiled-coil domain [15]. 
Therefore, it is possible that the WAFL coiled-coil 
domain may bind to KIAA0196 and/or KIAA1033. It 
is also reasonable that polyubiquitin (band #6 in Fig. 
1B) was co-immunoprecipitated with WAFL, since 
polyubiquitination is often required for endocytosis of 
cell-surface receptors [26], the proper delivery of 
proteins into the lumen of late endosomal multivesi-
cular bodies (MVBs), and the formation and scission 
of cargo-filled intralumenal vesicles [27]. 
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Fig. 2. Representative CID frag-
mentation profiles are given for in-
teracting proteins of 
WAFL/KIAA0674 identified by 
LC-MS/MS. (A) CID fragmentation 
profile of CLALQAQITALTK de-
rived from WAFL/KIAA0674 
(T00363). The monoisotopic mass of 
the neutral peptide is 1429.80 Da. 
Ions score is 59. b(2)-b(12) and 
y(2)-y(11) are matched with the 
peptide shown in the insert. (B) CID 
fragmentation profile of 
EEMVLDNIPK derived from 
KIAA0196 (Q53EL1_HUMAN). The 
monoisotopic mass of the neutral 
peptide is 1186.59 Da. Ions score is 
39. b(2)-b(9) and y(2)-y(9), except 
b(7), are matched with the peptide 
shown in the insert. (C) CID frag-
mentation profile of FLEEYTSQLR 
derived from KIAA1033 (Q2M389). 
The monoisotopic mass of the neu-
tral peptide is 1284.63 Da. Ions score 
is 44. b(2)-b(9) and y(2)-y(8) are 
continuously detected and matched 
with the peptide shown in the insert.  Int. J. Biol. Sci. 2010, 6 
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Fig. 3. Meta-analysis of WAFL and its interacting proteins. (A) Correlation network of WAFL and its interacting partners. 
Solid lines indicate the strongest correlation among all the combinations with partner genes, based on co-expression fre-
quencies of corresponding genes in the database, and dashed lines imply statistically significant, but less frequent than that of 
the strongest, correlations. (B-D) Gene ontology analysis of WAFL and its interacting partners. Top 1,000 genes 
co-expressed were selected from the PANTHER database, and statistically significantly (p < 0.01) enriched ontology cat-
egories were identified as molecular functions. The following three gene sets were analyzed: (B) WAFL, (C) KIAA0196, and 
(D) KIAA1033. Note that the ‘membrane traffic protein’ category is commonly enriched. 
 
WAFL has recently been implicated to associate 
with microtubule and actin cytoskeletons [15]. Indeed, 
TTBK2, which plays a role in cytoskeleton rear-
rangement during endocytosis, was also found in the 
multiple protein bands #3, #4 and #6, although the 
Mascot score was not as good as other proteins (Table 
1). TTBK2 is a member of the casein kinase group of 
eukaryotic protein kinases, as indicated by its ability 
to phosphorylate tau and tubulin in vitro [28]. The two 
TTBK2 phosphorylation sites in tau (Ser208 and 
Ser210) are priming sites for the phosphorylation of 
tau by GSK-3b, which is known to influence tau pa-
thology [29]. Mutations of TTKB2 cause spinocere-
bellarataxia type 11, and affected brain tissues show 
substantial cerebellar degeneration and tau deposition 
[30]. Therefore, it is likely that TTBK2 regulates cy-
toskeleton functions by phosphorylating tau and tu-
bulin. It was also reported that WAFL interacts with 
actin and WIP [13,15]. In the present mass spectro-
metry study, however, we failed to detect these inte-
ractions. If WAFL specifically interacts with F-actin, 
not monomeric actin molecules, as shown previously 
[15], it might be difficult to detect the interaction by 
using the co-immunoprecipitation approach. The 
WAFL-WIP interaction was previously detected using 
transfected cells expressing these proteins from plas-
mids. If the expression level of endogenous WIP was 
very low or the affinity between the two proteins was 
weak, it may also be difficult to detect the interaction. 
We have previously found that the gene expres-
sion of WAFL was consistently up-regulated in all UC 
patient biopsies investigated, although individual 
patient expression levels varied [14]. Furthermore, we 
have also previously found WAFL to be subject to Int. J. Biol. Sci. 2010, 6 
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conditional up-regulation of its mRNA expression in 
differentiating macrophages. As monocytes differen-
tiated into mature macrophages, interestingly, there 
was a 2.5-fold induction of WAFL [14]. This suggests 
that the expression of WAFL is conditionally regu-
lated and becomes elevated as the myeloid cell ac-
quires the characteristics of immuno-competent cells, 
which are active in endocytosis for processing anti-
gens. However, it is not ruled out that endocytosis is 
also important in other cells, such as B cells and T 
cells, involved in gut inflammation. 
 
4. Conclusion  
 The results in the present study suggest that the 
WAFL protein, a molecular marker for UC, may 
function as part of the CCV-mediated endocytosis 
machinery by interacting with AP2 through 
KIAA0196 and KIAA1033. The gene expression of 
WAFL may be up-regulated when monocytes are ac-
tivated and differentiate into macrophages, which are 
active in endocytosis. WAFL may also play a role in 
transport of early endosomes from the cell periphery 
to the perinuclear region by interacting with actin 
filaments and microtubules. Further analysis of inte-
racting network of WAFL, KIAA0196 and KIAA1033 
should elucidate their physiological and pathological 
roles in the processes of endocytosis and subsequent 
endosome trafficking.  
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